$AVXL

Anavex Life Sciences Corporation

Share on X

$AVXL

Anavex Life Sciences Corporation

Past 12mo:16mentions1voices

Share on X

All voices9 calls since Sep 2025show all

Loading price chart…

Frequently asked

Who mentions $AVXL most on Surfaced?

@adamfeuerstein (Adam Feuerstein ✡️) mentions $AVXL most — 16 mentions in the past 12 months.

When was $AVXL first mentioned on Surfaced?

The earliest tracked mention of $AVXL in the Surfaced archive was on Sep 9, 2025.

How many voices track $AVXL?

1 FinTwit voice has mentioned $AVXL 16 times in the past 12 months.

What kind of voices mention $AVXL most?

$AVXL is mentioned most by Biotech voices on Surfaced.

Recent calls

9 calls

@adamfeuersteinMay 6, 2026 · 1:03 PM

$AVXL CEO Chris Missling - fired. The 8K spells it out. Terminated for cause. https://t.co/HzBCPfX0gV One of biotech's worst peddlers of bullshit is gone. I might actually miss him. https://t.co/ZbDslD7jGj

Open on X

@adamfeuersteinMar 25, 2026 · 11:36 AM

$AVXL pulled its blarcamesine Alzheimer's application from the EMA after regulators there said there was no fking way it was going to approve a drug that does not work. <sad trombone>

Open on X

@adamfeuersteinDec 12, 2025 · 2:01 PM

$AVXL blarcarmesine formally rejected by EMA's CHMP advisers. The review is brutal: https://t.co/jMP61Cmplk https://t.co/S8UgDKktCE

Open on X

@adamfeuersteinNov 14, 2025 · 12:34 PM

$AVXL news, after all! CHMP negative trend vote. Goodbye! https://t.co/RmhXVsTYQK

Open on X

@adamfeuersteinNov 10, 2025 · 1:44 PM

$AVXL blarcamesine is on the CHMP agenda this week. Oral explanation hearing tomorrow. https://t.co/bqVqEYlxHo

Open on X

@adamfeuersteinOct 29, 2025 · 11:43 AM

$AVXL in full panic mode. With EMA rejection of blarcamesine looming, the company must be trying to sell as much stock as it can with the $150M ATM in place. That explains this morning's 🙄press release.

Open on X

@adamfeuersteinOct 23, 2025 · 12:42 PM

Time is running out for Anavex $AVXL and its treatment for Alzheimer’s disease. EMA rejection is coming. https://t.co/Q0BxxmB7s0

Open on X

@adamfeuersteinOct 13, 2025 · 12:17 PM

@jackbsadler $AVXL Likely too early, yes. “No withdrawal” is not positive news, also just too early. Either a rejection or withdrawal is coming 99.9999%, just a matter of when.

Open on X

@adamfeuersteinSep 9, 2025 · 11:40 AM

Every time you see another $AVXL press release touting some arcane analysis of blarcamesine in Alzheimer's disease, please remember: The drug failed, it does nothing, and CEO Chris Missling doesn't want to admit that European regulators are rejecting it.

Open on X